Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07036536

Non-Euploid Embryo Transfer (NEET) Registry

The NEET Registry is a registry to track and study the outcomes of non-euploid embryo transfers (NEET) in The Prelude Network

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Infertility Aneuploidy Chromosome Aberrations Genital Diseases Mosaicism Pathologic Processes Pathological Conditions, Signs and Symptoms Urogenital Diseases

Sex eligibility

Female

Study type

Observational

Primary location

Inception Fertility Research Institute

Houston, Texas, 77081, United States

Location status: Recruiting

Location contact

Amber Mendoza

CONTACT

[email protected]

346-393-2265

About this study

Preimplantation Genetic Testing for Aneuploidy (PGT-A) is widely offered as an option for patients pursuing pregnancy through in vitro fertilization (IVF). Most often, embryos with normal chromosome results are selected for transfer, with well established outcomes. However, for patient specific reasons, transferring an embryo with a non-euploid result (i.e. mosaic, isolated segmental aneuploid or aneuploidy of whole chromosome(s)) may be considered. Very little information is available on the long-term outcomes of mosaic embryo transfer. Even less has been published on outcomes for other types of non-euploid results. This study aims to collect prenatal, neonatal and pediatric outcome information for embryos transferred with the various types of non-euploid PGT-A results to better inform providers and patients in their decision making regarding such transfers.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient is planning a non-euploid embryo transfer (NEET) at a fertility clinic in The Prelude Network.
  • Patient has signed informed consent to participate in the registry.

Exclusion criteria

  • Not applicable

Treatment and study plan

Primary outcomes

  1. Rate of Embryo Implantation

    Time frame: 5 years

    The frequency of positive pregnancy test (blood serum QHCG) 10-14 days post embryo transfer

Other outcomes

  1. Rate of Ongoing Pregnancy

    Time frame: 5 years

    The frequency of fetal heart tone identified on ultrasound post embryo transfer around 10-12 weeks gestation

  2. Rate of Live Birth

    Time frame: 5 years

    The frequency of live birth post embryo transfer

  3. Rate of Spontaneous Abortion

    Time frame: 5 years

    The frequency of spontaneous abortion post embryo transfer

  4. Pediatric Developmental Milestones

    Time frame: 5 years

    Surveys inquiring about pediatric developmental milestones, as defined by the Center for Disease Control (CDC), are administered to the parent when child is 2 months, 6 months, 1 year, 2 year and 5 years of age. Results will be summarized.

Study contacts

Contact information is provided by the study sponsor or research team.

Amber Mendoza

CONTACT

[email protected]

346-393-2265

Sponsors and collaborators

Lead sponsor

Inception Fertility Research Institute, LLC

Industry

Collaborators

  • CooperSurgical Inc.
  • Igenomix

Registry information

Official study title

The NEET Registry: a Prospective, Observational Study for Outcomes of Non-euploid Embryo Transfers (NEET)

Important dates

Study start
2024
Primary completion
2030
Study completion
2030
First posted
Jun 25, 2025
Registry last updated
Jun 25, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.